I Sikazwe1, M A Elafros2, C M Bositis3, O K Siddiqi4,5,6, I J Koralnik4,5, L Kalungwana7, W H Theodore8, J F Okulicz9, M J Potchen10,11, G L Birbeck12,13. 1. HIV Prevention, Care and Treatment Program, Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia. 2. College of Human Medicine, Michigan State University (MSU), East Lansing, MI, USA. 3. Greater Lawrence Family Health Center, Lawrence, MA, USA. 4. Global Neurology Center, Division of Neuroimmunology, Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA. 5. Center for Virology and Vaccine Research, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA. 6. Department of Internal Medicine, University of Zambia, Lusaka, Zambia. 7. Department of Psychology, University of Zambia (UNZA), Lusaka, Zambia. 8. Clinical Epilepsy Unit, United States National Institutes of Health (US NIH), Bethesda, MD, USA. 9. HIV Evaluation Unit, Infectious Disease Service, San Antonio Military Medical Center, San Antonio, TX, USA. 10. Department of Imaging Sciences, University of Rochester, Rochester, NY, USA. 11. Lusaka Apex Medical School, Medical Radiation Sciences, Lusaka, Zambia. 12. Department of Neurology, University of Rochester, Rochester, NY, USA. 13. Epilepsy Care Team, Chikankata Hospital, Mazabuka, Zambia.
Abstract
OBJECTIVES: The aim of the study was to describe patient characteristics and outcomes among HIV-positive adults presenting to a Zambian tertiary care hospital with new-onset seizures. METHODS: From July 2011 to June 2013, adults with seizures and a known or probable diagnosis of HIV infection were screened for a cohort study. Demographic and clinical data were obtained, including information on engagement in HIV services and in-patient mortality. Analyses were conducted to identify characteristics associated with poor engagement in care and death. RESULTS: A total of 320 of 351 screened adults were HIV-positive, with 268 of 320 experiencing new-onset seizures. Of these, 114 of 268 (42.5%) were female, and their mean age was 36.8 years. Seventy-nine of the 268 patients (29.5%) were diagnosed with HIV infection during the index illness. Among those who were aware of their HIV-positive status, 59 of 156 (37.8%) had disengaged from care. Significant functional impairment (Karnofsky score < 50) was evident in 44.0% of patients. Cerebrospinal fluid was not obtained in 108 of 268 (40.3%). In-patient mortality outcomes were available for 214 patients, and 47 of these 214 (22.0%) died during hospitalization. Patients with significant functional impairment were more likely to undergo lumbar puncture (P = 0.046). Women and the functionally impaired were more likely to die (P = 0.04 and < 0.001, respectively). CONCLUSIONS: Despite the availability of care, less than half of HIV-infected people with new-onset seizures were actively engaged in care and in-patient mortality rates were high. In the absence of clinical contraindication, lumbar puncture should be performed to diagnose treatable conditions and reduce morbidity and mortality. Continued efforts are needed to expand community-based testing and improve HIV care retention rates. Qualitative studies are needed to elucidate factors contributing to lumbar puncture usage in this population.
OBJECTIVES: The aim of the study was to describe patient characteristics and outcomes among HIV-positive adults presenting to a Zambian tertiary care hospital with new-onset seizures. METHODS: From July 2011 to June 2013, adults with seizures and a known or probable diagnosis of HIV infection were screened for a cohort study. Demographic and clinical data were obtained, including information on engagement in HIV services and in-patient mortality. Analyses were conducted to identify characteristics associated with poor engagement in care and death. RESULTS: A total of 320 of 351 screened adults were HIV-positive, with 268 of 320 experiencing new-onset seizures. Of these, 114 of 268 (42.5%) were female, and their mean age was 36.8 years. Seventy-nine of the 268 patients (29.5%) were diagnosed with HIV infection during the index illness. Among those who were aware of their HIV-positive status, 59 of 156 (37.8%) had disengaged from care. Significant functional impairment (Karnofsky score < 50) was evident in 44.0% of patients. Cerebrospinal fluid was not obtained in 108 of 268 (40.3%). In-patient mortality outcomes were available for 214 patients, and 47 of these 214 (22.0%) died during hospitalization. Patients with significant functional impairment were more likely to undergo lumbar puncture (P = 0.046). Women and the functionally impaired were more likely to die (P = 0.04 and < 0.001, respectively). CONCLUSIONS: Despite the availability of care, less than half of HIV-infectedpeople with new-onset seizures were actively engaged in care and in-patient mortality rates were high. In the absence of clinical contraindication, lumbar puncture should be performed to diagnose treatable conditions and reduce morbidity and mortality. Continued efforts are needed to expand community-based testing and improve HIV care retention rates. Qualitative studies are needed to elucidate factors contributing to lumbar puncture usage in this population.
Authors: Stephanie M Topp; Julien M Chipukuma; Matimba M Chiko; Chibesa S Wamulume; Carolyn Bolton-Moore; Stewart E Reid Journal: Bull World Health Organ Date: 2011-03-31 Impact factor: 9.408
Authors: Omar K Siddiqi; Melissa A Elafros; Christopher M Bositis; Igor J Koralnik; William H Theodore; Jason F Okulicz; Lisa Kalungwana; Michael J Potchen; Izukanji Sikazwe; Gretchen L Birbeck Journal: Neurology Date: 2016-12-21 Impact factor: 9.910
Authors: Kiran T Thakur; Alexandra Boubour; Deanna Saylor; Mitashee Das; David R Bearden; Gretchen L Birbeck Journal: AIDS Date: 2019-02-01 Impact factor: 4.177
Authors: Mary C Spiciarich; Jane R von Gaudecker; Laura Jurasek; Dave F Clarke; Jorge Burneo; Jorge Vidaurre Journal: Curr Neurol Neurosci Rep Date: 2019-05-01 Impact factor: 5.081
Authors: Allison Navis; Ifunanya Dallah; Charles Mabeta; Kalo Musukuma; Omar K Siddiqi; Christopher M Bositis; Igor J Koralnik; Harris A Gelbard; William H Theodore; Jason F Okulicz; Brent A Johnson; Izukanji Sikazwe; David R Bearden; Gretchen L Birbeck Journal: Epilepsia Date: 2020-10-21 Impact factor: 5.864
Authors: Mathura Ravishankar; Ifunanya Dallah; Manoj Mathews; Christopher M Bositis; Musaku Mwenechanya; Lisa Kalungwana-Mambwe; David Bearden; Allison Navis; Melissa A Elafros; Harris Gelbard; William H Theodore; Igor J Koralnik; Jason F Okulicz; Brent A Johnson; Clara Belessiotis; Ornella Ciccone; Natalie Thornton; Melissa Tsuboyama; Omar K Siddiqi; Michael J Potchen; Izukanji Sikazwe; Gretchen L Birbeck Journal: Epilepsia Open Date: 2022-04-01
Authors: Melissa A Elafros; Brent A Johnson; Omar K Siddiqi; Jason F Okulicz; Izukanji Sikazwe; Christopher M Bositis; Michael J Potchen; Igor J Koralnik; William H Theodore; Lisa Kalungwana; Gretchen L Birbeck Journal: BMC Neurol Date: 2018-12-07 Impact factor: 2.474
Authors: Massimo Leone; Fausto Ciccacci; Stefano Orlando; Sandro Petrolati; Giovanni Guidotti; Noorjehan Abdul Majid; Victor Tamba Tolno; JeanBaptiste Sagno; Darlington Thole; Fabio Massimo Corsi; Michelangelo Bartolo; Maria Cristina Marazzi Journal: Int J Environ Res Public Health Date: 2021-03-09 Impact factor: 3.390
Authors: Melissa A Elafros; Clara Belessiotis-Richards; Gretchen L Birbeck; Virginia Bond; Izukanji Sikazwe; Michelle P Kvalsund Journal: Trans R Soc Trop Med Hyg Date: 2022-04-04 Impact factor: 2.455